Westwood Management Corp Natera, Inc. Transaction History

Westwood Management Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$36.93 - $56.68 $949,101 - $1.46 Million	25,700 New	25,700 $1.13 Million
Q1 2022 Apr 25, 2022	SELL	$30.32 - $91.33 $7.99 Million - $24.1 Million	-263,600 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$86.26 - $119.0 $3.25 Million - $4.49 Million	-37,700 Reduced 12.51%	263,600 $24.6 Million
Q3 2021 Oct 26, 2021	SELL	$100.17 - $126.36 $210,357 - $265,356	-2,100 Reduced 0.69%	301,300 $33.6 Million
Q2 2021 Jul 23, 2021	BUY	$86.05 - $119.72 $1.14 Million - $1.59 Million	13,300 Added 4.58%	303,400 $34.4 Million
Q1 2021 Apr 26, 2021	BUY	$91.47 - $124.36 $17 Million - $23.1 Million	185,700 Added 177.87%	290,100 $29.5 Million
Q4 2020 Jan 26, 2021	BUY	$66.66 - $111.74 $4.39 Million - $7.36 Million	65,900 Added 171.17%	104,400 $10.4 Million
Q3 2020 Oct 23, 2020	BUY	$45.89 - $72.67 $757,185 - $1.2 Million	16,500 Added 75.0%	38,500 $2.78 Million
Q2 2020 Jul 27, 2020	BUY	$26.36 - $49.86 $316,320 - $598,320	12,000 Added 120.0%	22,000 $1.1 Million
Q1 2020 Apr 27, 2020	BUY	$17.27 - $40.17 $172,700 - $401,700	10,000 New	10,000 $299,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Westwood Management Corp , based on Form 13F filings with the SEC.

Stay updated on Westwood Management Corp with notifications on news.